Recursion Pharmaceuticals Inc (RXRX) Insider Trading
- $2,787,850.00
- $33,247,454.10
- Aug. 18, 2025
- Blake Borgeson
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Aug. 18, 2025 | Insider | 36,599 | $5.52 | Sell | $202,026.48 | |
Nov. 13, 2024 | CFO | 15,000 | $7.66 | Sell | $114,900.00 | |
Nov. 12, 2024 | Director | 11,447 | $7.64 | Sell | $87,455.08 | |
Oct. 29, 2024 | Director | 11,447 | $6.72 | Sell | $76,923.84 | |
Oct. 24, 2024 | COO | 6,000 | $6.31 | Sell | $37,860.00 | |
Oct. 15, 2024 | Director | 11,447 | $6.67 | Sell | $76,351.49 | |
Oct. 8, 2024 | CFO | 15,000 | $6.32 | Sell | $94,800.00 | |
Oct. 2, 2024 | CEO | 20,000 | $6.16 | Sell | $123,200.00 | |
Oct. 1, 2024 | Director | 11,447 | $6.22 | Sell | $71,200.34 | |
Sept. 26, 2024 | COO | 6,000 | $7.00 | Sell | $42,000.00 | |
Sept. 17, 2024 | Director | 11,447 | $6.84 | Sell | $78,297.48 | |
Sept. 10, 2024 | CFO | 15,000 | $6.17 | Sell | $92,550.00 | |
Sept. 4, 2024 | CEO | 20,000 | $6.04 | Sell | $120,800.00 | |
Sept. 3, 2024 | Director | 11,447 | $6.27 | Sell | $71,772.69 | |
Aug. 29, 2024 | COO | 6,000 | $7.56 | Sell | $45,360.00 | |
Aug. 20, 2024 | Director | 11,447 | $7.12 | Sell | $81,502.64 | |
Aug. 13, 2024 | CFO | 15,000 | $6.35 | Sell | $95,250.00 | |
Aug. 7, 2024 | CEO | 30,000 | $7.10 | Sell | $213,000.00 | |
Aug. 6, 2024 | Director | 11,447 | $6.82 | Sell | $78,068.54 | |
July 25, 2024 | COO | 6,000 | $8.13 | Sell | $48,780.00 | |
July 23, 2024 | Director | 11,447 | $8.48 | Sell | $97,070.56 | |
July 10, 2024 | CEO | 50,000 | $7.48 | Sell | $374,000.00 | |
July 9, 2024 | CFO | 15,000 | $7.32 | Sell | $109,800.00 | |
July 9, 2024 | Director | 11,447 | $7.32 | Sell | $83,792.04 | |
June 27, 2024 | COO | 6,000 | $7.21 | Sell | $43,260.00 | |
June 25, 2024 | Director | 11,447 | $9.51 | Sell | $108,860.97 | |
June 13, 2024 | CFO | 15,000 | $9.32 | Sell | $139,800.00 | |
June 11, 2024 | Director | 11,447 | $8.45 | Sell | $96,727.15 | |
June 5, 2024 | CEO | 50,000 | $8.42 | Sell | $421,000.00 | |
May 30, 2024 | COO | 3,000 | $8.78 | Sell | $26,340.00 | |
May 28, 2024 | Director | 11,447 | $9.17 | Sell | $104,968.99 | |
May 1, 2024 | CEO | 50,000 | $7.73 | Sell | $386,500.00 | |
April 30, 2024 | Director | 11,447 | $7.95 | Sell | $91,003.65 | |
April 25, 2024 | COO | 3,000 | $7.67 | Sell | $23,010.00 | |
April 17, 2024 | CFO | 23,124 | $7.58 | Sell | $175,279.92 | |
April 16, 2024 | Director | 11,447 | $7.66 | Sell | $87,684.02 | |
April 3, 2024 | CEO | 40,000 | $8.84 | Sell | $353,600.00 | |
April 2, 2024 | Director | 11,447 | $8.82 | Sell | $100,962.54 | |
March 28, 2024 | CEO | 40,000 | $10.10 | Sell | $404,000.00 | |
March 21, 2024 | COO | 8,000 | $10.75 | Sell | $86,000.00 | |
March 19, 2024 | Director | 20,054 | $10.79 | Sell | $216,382.66 | |
March 13, 2024 | CFO | 25,000 | $11.03 | Sell | $275,750.00 | |
March 6, 2024 | CEO | 36,319 | $11.86 | Sell | $430,743.34 | |
March 5, 2024 | Director | 20,054 | $12.06 | Sell | $241,851.24 | |
Feb. 22, 2024 | COO | 8,000 | $14.89 | Sell | $119,120.00 | |
Feb. 20, 2024 | Director | 20,054 | $12.32 | Sell | $247,065.28 | |
Feb. 13, 2024 | CFO | 25,000 | $9.86 | Sell | $246,500.00 | |
Feb. 7, 2024 | CEO | 48,272 | $9.22 | Sell | $445,067.84 | |
Feb. 6, 2024 | Director | 11,447 | $9.30 | Sell | $106,457.10 | |
Jan. 25, 2024 | COO | 8,000 | $10.35 | Sell | $82,800.00 |
Insiders are both buying and selling Recursion Pharmaceuticals Inc stock.
The insider traders at Recursion Pharmaceuticals Inc are: Blake Borgeson, Christopher Gibson, Tina Marriott Larson, Michael Secora, Shafique Virani, Tina Marriott, Mubadala Investment Co Pjsc, Dean Y Li, Gibson Christopher, Zavain Dar, Najat Khan, and Terry-Ann Burrell
The most active insider trader at Recursion Pharmaceuticals Inc is Blake Borgeson with 53 trades.
Christopher Gibson has sold the most Recursion Pharmaceuticals Inc stock with a total value of $18,575,217.95.
Mubadala Investment Co Pjsc has bought the most Recursion Pharmaceuticals Inc stock with a total value of $3,191,575.00.
The most recent insider trade for Recursion Pharmaceuticals Inc was on Aug. 18, 2025.
The single biggest insider buy for Recursion Pharmaceuticals Inc was from Mubadala Investment Co Pjsc with a total value of $730,795.32 on Feb. 21, 2023.
The single biggest insider sell for Recursion Pharmaceuticals Inc was from Christopher Gibson with a total value of $2,190,000.00 on March 7, 2022.